Procalcitonin as a marker of Gram-negative bloodstream infections in hematological patients with febrile neutropenia
Procalcitonin as a marker of Gram-negative bloodstream infections in hematological patients with febrile neutropenia
复制标题
降钙素原作为发热性中性粒细胞减少症血液病患者革兰氏阴性血流感染的标志物
DOI:
10.1080/10428194.2019.1581928
复制
发表时间:
2019-08-24
影响因子:
2.6
通讯作者:
Yang, Ting
中科院分区:
文献类型:
--
作者:
Luo, Xiaofeng;Chen, Shaozhen;Yang, Ting
Abstract The aim of this study was to explore the predictive value of procalcitonin (PCT) in Gram-negative bloodstream infections (BSIs) in hematological patients with febrile neutropenia. A total of 1466 samples (396 blood culture (BC)-positive, 1052 BC-negative, and 18 contaminated specimens) were included, comprising 268 Gram-negative, 88 Gram-positive, 19 fungal, and 21 polymicrobial BSIs. Median PCT value (0.72 ng/mL; IQR: 0.23–3.87) was significantly higher in Gram-negative than Gram-positive (0.34 ng/mL; IQR: 0.14–2.23; p < .01), or fungal (0.27 ng/mL; IQR: 0.13–0.40; p < .01) BSIs. In mono-microbial BSIs, the best PCT cutoff distinguishing Gram-negative BSIs from all other fever causes was 0.56 ng/ml, with a specificity of 76.8%. PCT levels were significantly higher in BSIs from multidrug-resistant (MDR) Gram-negative strains than from non-MDR (p < .01). This study confirms that elevated PCT may predict Gram-negative BSIs in hematological patients with febrile neutropenia, and demonstrates higher PCT levels in MDR Gram-negative BSIs in these patients.